XORTX Therapeutics (XRTX) has submitted a Type C meeting request with the US Food and Drug Administration regarding the Company’s XRx-026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback